Premium
[P3–167]: DEVELOPMENT OF AN IPSC‐BASED BIOMARKER STRATEGY TO IDENTIFY NEUROREGENERATIVE RESPONDERS TO ALLOPREGNANOLONE
Author(s) -
Solinsky Christine M.,
Park Jenny Ayoung,
Chui Helena C.,
BlurtonJones Mathew,
Ichida Justin K.,
Diaz Brinton Roberta
Publication year - 2017
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2017.06.1379
Subject(s) - induced pluripotent stem cell , neural stem cell , allopregnanolone , medicine , biology , neuroscience , stem cell , oncology , microbiology and biotechnology , embryonic stem cell , gabaa receptor , receptor , neuroactive steroid , biochemistry , gene
Madhav Thambisetty, Cristina Legido-Quigley, King’s College London, London, United Kingdom; Kings College London, London, United Kingdom; Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, United Kingdom; NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia at South London and Maudsley NHS Foundation, London, United Kingdom; Johns Hopkins University School of Medicine, Baltimore, MD, USA; Duke University, Durham, NC, USA; National Institute on Aging, Baltimore, MD, USA. Contact e-mail: stuart.snowden@kcl.ac.uk